Skip to main content

Intramural Hematoma clinical trials at UCSD

1 research study open to eligible people

Showing trials for
  • NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness

    open to eligible people ages 18 years and up

    Prospective, non-randomized, multi-center clinical investigation of the NEXUS™ Aortic Arch Stent Graft System (NEXUSTM) for the treatment of thoracic aortic lesions involving the aortic arch with a proximal landing zone, native or previously implanted surgical graft, in the ascending aorta and with a brachiocephalic trunk native landing zone.

    La Jolla, California and other locations

Our lead scientists for Intramural Hematoma research studies include .

Last updated: